Global Antiandrogen Monotherapy Sales Market Report 2016

September 2016 | 122 pages | ID: GB7DFEA3E77EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antiandrogen Monotherapy

Revenue, means the sales value of Antiandrogen Monotherapy

This report studies sales (consumption) of Antiandrogen Monotherapy in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Pfizer Inc. (USA)
• Abbott Laboratories (USA)
• Genentech Inc. (USA)
• GlaxoSmithKline Plc (UK)
• Immunomedics, Inc. (USA)
• Indevus Pharmaceuticals Inc. (USA)
• Novartis AG (Switzerland)
• OSI Pharmaceuticals, Inc. (USA)
• Paladin Labs Inc. (Canada)
• ALZA Corporation (USA)
• Amgen Inc. (USA)
• AstraZeneca PLC (UK)
• Medimmune, LLC (USA)
• Bristol-Myers Squibb Company (USA)
• Cell Genesys Inc. (USA)
• Dendreon Corporation (USA)
• EUSA Pharma, (USA) Inc. (USA)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Progenics Pharmaceuticals, Inc. (USA)
• Sanofi-Aventis SA (France)
• Spectrum Pharmaceuticals, Inc. (USA)
• Takeda Pharmaceutical Company Limited (Japan)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antiandrogen Monotherapy in these regions, from 2011 to 2021 (forecast), like

• USA
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Antiandrogen Monotherapy in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Antiandrogen Monotherapy Sales Market Report 2016

1 ANTIANDROGEN MONOTHERAPY OVERVIEW

1.1 Product Overview and Scope of Antiandrogen Monotherapy
1.2 Classification of Antiandrogen Monotherapy
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Antiandrogen Monotherapy
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Antiandrogen Monotherapy Market by Regions
  1.4.1 USA Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Antiandrogen Monotherapy (2011-2021)
  1.5.1 Global Antiandrogen Monotherapy Sales and Growth Rate (2011-2021)
  1.5.2 Global Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)

2 GLOBAL ANTIANDROGEN MONOTHERAPY COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Antiandrogen Monotherapy Market Competition by Manufacturers
  2.1.1 Global Antiandrogen Monotherapy Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Antiandrogen Monotherapy Revenue and Share by Manufacturers (2011-2016)
2.2 Global Antiandrogen Monotherapy (Volume and Value) by Type
  2.2.1 Global Antiandrogen Monotherapy Sales and Market Share by Type (2011-2016)
  2.2.2 Global Antiandrogen Monotherapy Revenue and Market Share by Type (2011-2016)
2.3 Global Antiandrogen Monotherapy (Volume and Value) by Regions
  2.3.1 Global Antiandrogen Monotherapy Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Antiandrogen Monotherapy Revenue and Market Share by Regions (2011-2016)
2.4 Global Antiandrogen Monotherapy (Volume) by Application

3 USA ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

3.1 USA Antiandrogen Monotherapy Sales and Value (2011-2016)
  3.1.1 USA Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
  3.1.2 USA Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
  3.1.3 USA Antiandrogen Monotherapy Sales Price Trend (2011-2016)
3.2 USA Antiandrogen Monotherapy Sales and Market Share by Manufacturers
3.3 USA Antiandrogen Monotherapy Sales and Market Share by Type
3.4 USA Antiandrogen Monotherapy Sales and Market Share by Application

4 CHINA ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

4.1 China Antiandrogen Monotherapy Sales and Value (2011-2016)
  4.1.1 China Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
  4.1.2 China Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
  4.1.3 China Antiandrogen Monotherapy Sales Price Trend (2011-2016)
4.2 China Antiandrogen Monotherapy Sales and Market Share by Manufacturers
4.3 China Antiandrogen Monotherapy Sales and Market Share by Type
4.4 China Antiandrogen Monotherapy Sales and Market Share by Application

5 EUROPE ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Antiandrogen Monotherapy Sales and Value (2011-2016)
  5.1.1 Europe Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
  5.1.2 Europe Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Antiandrogen Monotherapy Sales Price Trend (2011-2016)
5.2 Europe Antiandrogen Monotherapy Sales and Market Share by Manufacturers
5.3 Europe Antiandrogen Monotherapy Sales and Market Share by Type
5.4 Europe Antiandrogen Monotherapy Sales and Market Share by Application

6 JAPAN ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Antiandrogen Monotherapy Sales and Value (2011-2016)
  6.1.1 Japan Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
  6.1.2 Japan Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Antiandrogen Monotherapy Sales Price Trend (2011-2016)
6.2 Japan Antiandrogen Monotherapy Sales and Market Share by Manufacturers
6.3 Japan Antiandrogen Monotherapy Sales and Market Share by Type
6.4 Japan Antiandrogen Monotherapy Sales and Market Share by Application

7 INDIA ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

7.1 India Antiandrogen Monotherapy Sales and Value (2011-2016)
  7.1.1 India Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
  7.1.2 India Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
  7.1.3 India Antiandrogen Monotherapy Sales Price Trend (2011-2016)
7.2 India Antiandrogen Monotherapy Sales and Market Share by Manufacturers
7.3 India Antiandrogen Monotherapy Sales and Market Share by Type
7.4 India Antiandrogen Monotherapy Sales and Market Share by Application

8 SOUTHEAST ASIA ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Antiandrogen Monotherapy Sales and Value (2011-2016)
  8.1.1 Southeast Asia Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
  8.1.2 Southeast Asia Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
  8.1.3 Southeast Asia Antiandrogen Monotherapy Sales Price Trend (2011-2016)
8.2 Southeast Asia Antiandrogen Monotherapy Sales and Market Share by Manufacturers
8.3 Southeast Asia Antiandrogen Monotherapy Sales and Market Share by Type
8.4 Southeast Asia Antiandrogen Monotherapy Sales and Market Share by Application

9 GLOBAL ANTIANDROGEN MONOTHERAPY MANUFACTURERS ANALYSIS

9.1 Pfizer Inc. (USA)
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Antiandrogen Monotherapy Product Type, Application and Specification
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Pfizer Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Abbott Laboratories (USA)
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 122 Product Type, Application and Specification
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Abbott Laboratories (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 Genentech Inc. (USA)
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 142 Product Type, Application and Specification
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Genentech Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline Plc (UK)
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Aug Product Type, Application and Specification
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 Immunomedics, Inc. (USA)
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Product Type, Application and Specification
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Immunomedics, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 Indevus Pharmaceuticals Inc. (USA)
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Million USD Product Type, Application and Specification
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Novartis AG (Switzerland)
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Pharma & Healthcare Product Type, Application and Specification
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Novartis AG (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 OSI Pharmaceuticals, Inc. (USA)
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Product Type, Application and Specification
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview
9.9 Paladin Labs Inc. (Canada)
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Product Type, Application and Specification
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.9.4 Main Business/Business Overview
9.10 ALZA Corporation (USA)
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Product Type, Application and Specification
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 ALZA Corporation (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  9.10.4 Main Business/Business Overview
9.11 Amgen Inc. (USA)
9.12 AstraZeneca PLC (UK)
9.13 Medimmune, LLC (USA)
9.14 Bristol-Myers Squibb Company (USA)
9.15 Cell Genesys Inc. (USA)
9.16 Dendreon Corporation (USA)
9.17 EUSA Pharma, (USA) Inc. (USA)
9.18 F. Hoffmann-La Roche Ltd. (Switzerland)
9.19 Progenics Pharmaceuticals, Inc. (USA)
9.20 Sanofi-Aventis SA (France)
9.21 Spectrum Pharmaceuticals, Inc. (USA)
9.22 Takeda Pharmaceutical Company Limited (Japan)

10 ANTIANDROGEN MONOTHERAPY MAUFACTURING COST ANALYSIS

10.1 Antiandrogen Monotherapy Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Antiandrogen Monotherapy

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Antiandrogen Monotherapy Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET FORECAST (2016-2021)

14.1 Global Antiandrogen Monotherapy Sales, Revenue Forecast (2016-2021)
14.2 Global Antiandrogen Monotherapy Sales Forecast by Regions (2016-2021)
14.3 Global Antiandrogen Monotherapy Sales Forecast by Type (2016-2021)
14.4 Global Antiandrogen Monotherapy Sales Forecast by Application (2016-2021)

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antiandrogen Monotherapy
Table Classification of Antiandrogen Monotherapy
Figure Global Sales Market Share of Antiandrogen Monotherapy by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Antiandrogen Monotherapy
Figure Global Sales Market Share of Antiandrogen Monotherapy by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure China Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure Europe Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure Japan Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure India Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure Global Antiandrogen Monotherapy Sales and Growth Rate (2011-2021)
Figure Global Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Table Global Antiandrogen Monotherapy Sales of Key Manufacturers (2011-2016)
Table Global Antiandrogen Monotherapy Sales Share by Manufacturers (2011-2016)
Figure 2015 Antiandrogen Monotherapy Sales Share by Manufacturers
Figure 2016 Antiandrogen Monotherapy Sales Share by Manufacturers
Table Global Antiandrogen Monotherapy Revenue by Manufacturers (2011-2016)
Table Global Antiandrogen Monotherapy Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Antiandrogen Monotherapy Revenue Share by Manufacturers
Table 2016 Global Antiandrogen Monotherapy Revenue Share by Manufacturers
Table Global Antiandrogen Monotherapy Sales and Market Share by Type (2011-2016)
Table Global Antiandrogen Monotherapy Sales Share by Type (2011-2016)
Figure Sales Market Share of Antiandrogen Monotherapy by Type (2011-2016)
Figure Global Antiandrogen Monotherapy Sales Growth Rate by Type (2011-2016)
Table Global Antiandrogen Monotherapy Revenue and Market Share by Type (2011-2016)
Table Global Antiandrogen Monotherapy Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antiandrogen Monotherapy by Type (2011-2016)
Figure Global Antiandrogen Monotherapy Revenue Growth Rate by Type (2011-2016)
Table Global Antiandrogen Monotherapy Sales and Market Share by Regions (2011-2016)
Table Global Antiandrogen Monotherapy Sales Share by Regions (2011-2016)
Figure Sales Market Share of Antiandrogen Monotherapy by Regions (2011-2016)
Figure Global Antiandrogen Monotherapy Sales Growth Rate by Regions (2011-2016)
Table Global Antiandrogen Monotherapy Revenue and Market Share by Regions (2011-2016)
Table Global Antiandrogen Monotherapy Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Antiandrogen Monotherapy by Regions (2011-2016)
Figure Global Antiandrogen Monotherapy Revenue Growth Rate by Regions (2011-2016)
Table Global Antiandrogen Monotherapy Sales and Market Share by Application (2011-2016)
Table Global Antiandrogen Monotherapy Sales Share by Application (2011-2016)
Figure Sales Market Share of Antiandrogen Monotherapy by Application (2011-2016)
Figure Global Antiandrogen Monotherapy Sales Growth Rate by Application (2011-2016)
Figure USA Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure USA Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure USA Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table USA Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table USA Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table USA Antiandrogen Monotherapy Sales by Type (2011-2016)
Table USA Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table USA Antiandrogen Monotherapy Sales by Application (2011-2016)
Table USA Antiandrogen Monotherapy Market Share by Application (2011-2016)
Figure China Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure China Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure China Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table China Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table China Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table China Antiandrogen Monotherapy Sales by Type (2011-2016)
Table China Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table China Antiandrogen Monotherapy Sales by Application (2011-2016)
Table China Antiandrogen Monotherapy Market Share by Application (2011-2016)
Figure Europe Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure Europe Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure Europe Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table Europe Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table Europe Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table Europe Antiandrogen Monotherapy Sales by Type (2011-2016)
Table Europe Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table Europe Antiandrogen Monotherapy Sales by Application (2011-2016)
Table Europe Antiandrogen Monotherapy Market Share by Application (2011-2016)
Figure Japan Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure Japan Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure Japan Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table Japan Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table Japan Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table Japan Antiandrogen Monotherapy Sales by Type (2011-2016)
Table Japan Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table Japan Antiandrogen Monotherapy Sales by Application (2011-2016)
Table Japan Antiandrogen Monotherapy Market Share by Application (2011-2016)
Figure India Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure India Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure India Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table India Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table India Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table India Antiandrogen Monotherapy Sales by Type (2011-2016)
Table India Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table India Antiandrogen Monotherapy Sales by Application (2011-2016)
Table India Antiandrogen Monotherapy Market Share by Application (2011-2016)
Figure Southeast Asia Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure Southeast Asia Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Sales by Type (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Sales by Application (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Market Share by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Genentech Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Immunomedics, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG (Switzerland) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ALZA Corporation (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Amgen Inc. (USA) Basic Information List
Table Amgen Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca PLC (UK) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medimmune, LLC (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Company (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cell Genesys Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Dendreon Corporation (USA) Basic Information List
Table Dendreon Corporation (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon Corporation (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Basic Information List
Table EUSA Pharma, (USA) Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure EUSA Pharma, (USA) Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List
Table Progenics Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Progenics Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Sanofi-Aventis SA (France) Basic Information List
Table Sanofi-Aventis SA (France) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Aventis SA (France) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List
Table Spectrum Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Spectrum Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Company Limited (Japan) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen Monotherapy
Figure Manufacturing Process Analysis of Antiandrogen Monotherapy
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015
Table Major Buyers of Antiandrogen Monotherapy
Table Distributors/Traders List
Figure Global Antiandrogen Monotherapy Sales and Growth Rate Forecast (2016-2021)
Figure Global Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2016-2021)
Table Global Antiandrogen Monotherapy Sales Forecast by Regions (2016-2021)
Table Global Antiandrogen Monotherapy Sales Forecast by Type (2016-2021)
Table Global Antiandrogen Monotherapy Sales Forecast by Application (2016-2021)